Fordham Notes: PEDs discussed at the Fordham Sports Law Symposium

Friday, February 14, 2014

PEDs discussed at the Fordham Sports Law Symposium

One of the main topics up for discussion in the Fordham Sports Law Forum’s 18th Annual Symposium on Current Legal Issues in Sports on Feb. 14 couldn’t have been more timely.

In a year in which Major League Baseball suspended New York Yankees’ third baseman Alex Rodriguez for performance enhancement drug use for the entire 2014 season, panelists at the Fordham Sports Law Forum Symposium discussed arguments surrounding the permissibility of performance enhancement.

The all-day event also debated hip-hop mogul Jay Z’s venture into sports (“The New Face of Sports Agency: The Runner Rule and Roc Nation’s Challenge to Traditional Notions of Athlete Representation”), and efforts by a group of American Indians who filed a petition in an attempt to cancel all of the Washington ‘Redskins’ and related trademarks registered by the team (Marooning the Mascot: The Implications of Blackhorse v. Pro-Football.)

This is the 18th year for the symposium, which has attracted many of the top practitioners in the industry.

Check out this compilation of tweets during the performance enhancement drugs discussion featuring Marc Edelman, an adjunct at Fordham Law and an associate professor of law at the Zicklin School of Business, Baruch College, and Arthur Caplan, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics at NYU Langone Medical Center, on STORIFY.

-Gina Vergel

No comments: